These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
691 related articles for article (PubMed ID: 19166399)
1. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months]. Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399 [TBL] [Abstract][Full Text] [Related]
2. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death]. Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992 [TBL] [Abstract][Full Text] [Related]
3. [The prognostic role of extremely high levels of the B-type natriuretic prohormone with regard to the in-hospital mortality of patients hospitalized for heart failure]. Bózsik B; Nagy E; Somlói M; Tomcsányi J Orv Hetil; 2017 May; 158(20):779-782. PubMed ID: 28502208 [TBL] [Abstract][Full Text] [Related]
4. Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels? Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE Eur J Heart Fail; 2015 Sep; 17(9):936-44. PubMed ID: 26222618 [TBL] [Abstract][Full Text] [Related]
5. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study. Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696 [TBL] [Abstract][Full Text] [Related]
6. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment. Stienen S; Salah K; Dickhoff C; Carubelli V; Metra M; Magrini L; Di Somma S; Tijssen JP; Pinto YM; Kok WE J Card Fail; 2015 Nov; 21(11):930-4. PubMed ID: 26216495 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure]. Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545 [TBL] [Abstract][Full Text] [Related]
8. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure. Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322 [TBL] [Abstract][Full Text] [Related]
9. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome. Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808 [TBL] [Abstract][Full Text] [Related]
10. Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial. Greene SJ; Maggioni AP; Fonarow GC; Solomon SD; Böhm M; Kandra A; Prescott MF; Reimund B; Hua TA; Lesogor A; Zannad F; Gheorghiade M; Eur J Heart Fail; 2015 Jan; 17(1):98-108. PubMed ID: 25597870 [TBL] [Abstract][Full Text] [Related]
12. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure. Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936 [TBL] [Abstract][Full Text] [Related]
13. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score. Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction. Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719 [TBL] [Abstract][Full Text] [Related]
15. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
16. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure. Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712 [TBL] [Abstract][Full Text] [Related]
17. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center. Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406 [TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department. Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL; Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961 [TBL] [Abstract][Full Text] [Related]